Can biomaterials offer novel therapeutic strategies against COVID-19?

The global coronavirus disease 2019 (COVID-19) pandemic rages on. To date, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative…

Vir, GSK to Halt Enrollment in US COVID-19 Antibody Trial Substudy

Vir Biotechnology and Britain’s GSK said on Wednesday they would pause enrollment into a study testing their experimental COVID-19 antibody…

Insilico Medicine discovers novel preclinical candidate to address idiopathic pulmonary fibrosis

Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence (“AI”) and drug discovery — linking together generative chemistry and biology…